Skip to content

ReportsLRCX10-K FY2026

SEC filings, compared

What changed in Lam Research's 10-K for the fiscal year ended June 28, 2026

Compared with the 10-K for the fiscal year ended June 29, 2025. Item 1A and Item 7 analysed; every summary checked against the quoted filing text.

Registrant
LAM RESEARCH CORP · LRCX
This filing
0000707549-26-000037 · filed Aug 7, 2026
Compared with
0000707549-25-000075 · filed Aug 11, 2025
Processed
Sep 20, 2026 UTC · parser-v5 · classify-v4 · select-v1

Research tool. Describes what filings say. Not investment advice. Verify independently. Read the cited paragraph before relying on it.

How a report is made

111 material changes among 172 changed paragraphs

18 shown by default across the three sections below; each section's "Show all" reaches the rest, in filing order.

Numbers from XBRL

Each figure is the one the filing itself tagged, taken from the filing that reported it. Not written by a model.

ConceptFY2026FY2025Change (our arithmetic)
Revenueus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax23,232,690,000USD · Jun 30, 2025 to Jun 28, 202618,435,591,000USD · Jul 1, 2024 to Jun 29, 2025+4,797,099,000+26%
Net income or lossus-gaap:NetIncomeLoss7,265,396,000USD · Jun 30, 2025 to Jun 28, 20265,358,217,000USD · Jul 1, 2024 to Jun 29, 2025+1,907,179,000+35.6%
Cash and cash equivalentsus-gaap:CashAndCashEquivalentsAtCarryingValue5,579,171,000USD · at Jun 28, 20266,390,659,000USD · at Jun 29, 2025−811,488,000−12.7%
Net cash from operating activitiesus-gaap:NetCashProvidedByUsedInOperatingActivities5,857,657,000USD · Jun 30, 2025 to Jun 28, 20266,173,264,000USD · Jul 1, 2024 to Jun 29, 2025−315,607,000−5.1%

Values as tagged in the filing's inline XBRL, resolved by accession rather than by period matching. When a value is not tagged, we show that instead of estimating it. FY2026: 0000707549-26-000037 · FY2025: 0000707549-25-000075

What the company says for the first time

Paragraphs with no counterpart in the prior filing.

25 material additions

Item 1A · Risk Factors

4 of 13 shown · Ordered by the model, quote-checked

01AddedItem 1A › Our Revenues and Results of Operations Are Variable › We Use Artificial Intelligence in Our Business, and Challenges with Properly Managing Its Use Could Result in Reputational Harm, Competitive Harm, and Legal Liability, and Materially and Adversely Affect Our Results of Operations.

Summary · quote-checked

Added disclosure that Chinese rare-earth export controls and licensing requirements could disrupt sourcing, increase costs, impose compliance burdens, and affect production and financial results.

This newly added paragraph identifies specific government controls, supplier and licensing dependencies, potential production constraints, increased costs, and adverse effects on the business.

Why the model ranked it here

Clients should read this because newly disclosed rare-earth export controls could disrupt suppliers, constrain production, increase costs, and impair financial results.

Filing text · FY2025 10-K · filed Aug 11, 2025

No corresponding language in the FY2025 10-K.

Filing text · FY2026 10-K · filed Aug 7, 2026

Tariffs, export controls, additional taxes, trade barriers, sanctions, the termination or modification of trade agreements, trade zones, and other duty mitigation initiatives, and any reciprocal retaliatory actions, can increase our manufacturing costs, decrease margins, reduce the competitiveness of our products, disrupt our supply chain operations, or inhibit our ability to sell products or provide services, all of which has had and in the future could have a material adverse effect on our business, results of operations, or financial condition. For example, our business requires steel and aluminum to manufacture our products, and the imposition of tariffs on steel and aluminum imports into the United States increased our manufacturing costs in fiscal year 2026, which adversely impacted our margins. Certain of our international sales depend on our ability to obtain export licenses from the U.S. or foreign governments. Our inability to obtain such licenses, or an expansion of the number or kinds of sales for which export licenses are required, has limited and could in the future further limit the market for our products and has had and could in the future have an adverse impact on our revenues. As is discussed below under the heading "Our Sales to Customers in China, a Significant Region for Us, Have Been Impacted, and are Likely to Be Materially and Adversely Affected by Export License Requirements and Other Regulatory Changes, or Other Governmental Actions in the Course of the Trade Relationship Between the U.S. and China," the U.S. government has in recent years imposed new controls, including expanded export license requirements and restrictions on sales to certain Chinese entities that significantly impact trade with China. In addition, the U.S. government has an ongoing process of assessing technologies that may be subject to new or additional export controls, and it is possible that such additional controls, if and when imposed, could further adversely impact our ability to sell our products outside the United States. The implementation by the U.S. government of broad export controls restricting access to our technology (such as recent controls limiting exports to China) may cause customers with international operations to reconsider their use of and reliance on our products, which could adversely impact our future revenue and profits and strengthen competitors who are not subject to such restrictions. Furthermore, there are risks that foreign governments may, among other things, take retaliatory actions; insist on the use of local suppliers; compel companies to partner with local companies to design and supply equipment on a local basis, requiring the transfer of intellectual property rights and/or local manufacturing; utilize their influence over their judicial systems to respond to intellectual property disputes or issues; and provide special incentives to government-backed local customers to buy from local competitors, even if their products are inferior to ours; all of which could adversely impact our ability to compete as well as our revenues and margins. For example, China is the primary source of supply of certain rare earth elements critical to the manufacture of certain of our products. [added] The Chinese government has imposed export controls and license requirements on certain rare earth elements and on certain products that contain Chinese-origin rare earth elements that are manufactured outside of China (which have been suspended in part until November 2026 (unless extended)) and could expand such controls or licensing requirements in the future. Such measures could delay or prevent our suppliers from sourcing the materials, or producing the components, required for us to manufacture our products, and increase the costs of such materials or components. In addition, to the extent these controls require us to obtain export licenses for certain products manufactured outside of China, we would experience increased compliance burdens, may be unable to obtain the required licenses, and may be unable to obtain materials or components necessary to meet our production requirements or product specifications in a timely manner, or at all, or on commercially acceptable terms. The occurrence of any of these risks could materially and adversely affect our business, results of operations, financial condition, and margins.

Cite this change

"The Chinese government has imposed export controls and license requirements on certain rare earth elements and on certain products that contain Chinese-origin rare earth elements that are manufactured outside of China (which have been suspended in part until November 2026 (unless extended)) and could expand such controls or licensing requirements in the future. Such measures could delay or prevent our suppliers from sourcing the materials, or producing the components, required for us to manufacture our products, and increase the costs of such materials or components. In addition, to the extent these controls require us to obtain export licenses for certain products manufactured outside of China, we would experience increased compliance burdens, may be unable to obtain the required licenses, and may be unable to obtain materials or components necessary to meet our production requirements or product specifications in a timely manner, or at all, or on commercially acceptable terms. The occurrence of any of these risks could materially and adversely affect our business, results of operations, financial condition, and margins."

Lam Research, Form 10-K for FY2026, Item 1A, accession 0000707549-26-000037, filed 7 August 2026.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754926000037/lrcx-20260628.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

02AddedItem 1A › Our Revenues and Results of Operations Are Variable

Summary · quote-checked

Adds disclosure that evolving cyber threats and increasingly adopted AI capabilities may create novel vulnerabilities, unauthorized access, data leakage, and sophisticated attacks.

The new paragraph introduces substantive cybersecurity, AI, intellectual-property, data-access, and operational risks, including specific attack mechanisms and potential adverse impacts.

Why the model ranked it here

Clients should read this because evolving cyber threats and AI-enabled vulnerabilities could expose sensitive information and materially disrupt operations.

Filing text · FY2025 10-K · filed Aug 11, 2025

No corresponding language in the FY2025 10-K.

Filing text · FY2026 10-K · filed Aug 7, 2026

The technology, data, intellectual property and other sensitive information we seek to protect, and the information systems used to store, process, or transmit such information, are subject to loss, unauthorized access, unauthorized release, misappropriation, misuse, disruption, breach, degradation, or failure, any of which could have a material adverse effect on our business or operations. Such events may result from various possible causes, including mistakes or unauthorized actions by our employees, contractors, or other third parties, or cyberattacks or other malicious activities by third parties, including industrial, corporate, or other espionage, criminal hackers, or state-sponsored intrusions, by methods that include exploitation of known or unknown software or hardware vulnerabilities, viruses, malware, ransomware, social engineering (such as phishing schemes), credential harvesting, denial of service attacks, destructive or inadequate code, software or hardware failure, power failures, or physical damage to computers, hard drives, communication lines, or networking equipment, in each case with respect to us or the third-party product and service providers upon which we rely. We or our third-party product and service providers may not be able to anticipate, identify, or implement effective preventive measures against cyberattacks or data security incidents and, even if timely identified, we or our third-party product and service providers may not be able to remediate such attacks or incidents in a timely and effective manner, or to mitigate or avoid adverse impacts resulting from any such attacks or incidents. [added] These threats continue to evolve and may include the use of tools and techniques that change frequently or may be disguised or difficult to detect, or designed to circumvent security controls, evade detection, or remove forensic evidence, or remain dormant until a triggering event, or that may continue undetected for an extended period of time, which may hinder our or our third-party product and service providers' ability to identify, investigate, and remediate attacks or incidents in a timely and effective manner, or to mitigate or avoid adverse impacts resulting from any such attacks or incidents. In addition, the development and deployment of AI models, tools, and other applications expose us, our customers, suppliers, and other third-party providers to increased and novel risks and vulnerabilities, including prompt injection, hallucinations, errors, and other issues related to AI agents, as well as the risk of compromise of valuable intellectual property. For example, the autonomous nature of agentic AI increases the risk that agents learn to circumvent security controls, and certain generative AI systems and large language models may, in order to satisfy user prompts, access or retrieve data using the credentials, permissions, or access rights of the user or connected systems, which may increase the risk of unauthorized access, data leakage, or improper use of sensitive or proprietary information. To the extent AI capabilities improve and are increasingly adopted, they may be used to introduce, identify, or exploit vulnerabilities and to implement increasingly sophisticated cybersecurity attacks and could materially and adversely impact our business or operations. In addition, even if we or our third-party product and service providers are able to develop patches or other mitigations to address newly identified vulnerabilities, the pace at which AI enables the discovery and exploitation of such vulnerabilities may exceed our or our third-party product and service providers' ability to implement such patches and mitigations quickly enough to prevent the exploitation of such vulnerabilities.

Cite this change

"These threats continue to evolve and may include the use of tools and techniques that change frequently or may be disguised or difficult to detect, or designed to circumvent security controls, evade detection, or remove forensic evidence, or remain dormant until a triggering event, or that may continue undetected for an extended period of time, which may hinder our or our third-party product and service providers' ability to identify, investigate, and remediate attacks or incidents in a timely and effective manner, or to mitigate or avoid adverse impacts resulting from any such attacks or incidents. In addition, the development and deployment of AI models, tools, and other applications expose us, our customers, suppliers, and other third-party providers to increased and novel risks and vulnerabilities, including prompt injection, hallucinations, errors, and other issues related to AI agents, as well as the risk of compromise of valuable intellectual property. For example, the autonomous nature of agentic AI increases the risk that agents learn to circumvent security controls, and certain generative AI systems and large language models may, in order to satisfy user prompts, access or retrieve data using the credentials, permissions, or access rights of the user or connected systems, which may increase the risk of unauthorized access, data leakage, or improper use of sensitive or proprietary information. To the extent AI capabilities improve and are increasingly adopted, they may be used to introduce, identify, or exploit vulnerabilities and to implement increasingly sophisticated cybersecurity attacks and could materially and adversely impact our business or operations."

Lam Research, Form 10-K for FY2026, Item 1A, accession 0000707549-26-000037, filed 7 August 2026.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754926000037/lrcx-20260628.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

03AddedItem 1A › Our Revenues and Results of Operations Are Variable

Summary · quote-checked

Adds a risk concerning customer relationship disruptions or lost business arising from compliance issues or breaches of customer trust.

The new bullet discloses a substantive customer-related dependency and potential causes of lost business, constituting a newly stated risk rather than wording or boilerplate.

Why the model ranked it here

Clients should read this because compliance failures or breaches of customer trust are newly identified as potential causes of relationship disruption and lost business.

Filing text · FY2025 10-K · filed Aug 11, 2025

No corresponding language in the FY2025 10-K.

Filing text · FY2026 10-K · filed Aug 7, 2026

[added] • any disruption to our relationship with, or loss of business from, customers, including due to actual or alleged non-compliance with contractual or other customer requirements, applicable laws, rules, or regulations, or breaches of customer trust;

Cite this change

"any disruption to our relationship with, or loss of business from, customers, including due to actual or alleged non-compliance with contractual or other customer requirements, applicable laws, rules, or regulations, or breaches of customer trust;"

Lam Research, Form 10-K for FY2026, Item 1A, accession 0000707549-26-000037, filed 7 August 2026.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754926000037/lrcx-20260628.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

04AddedItem 1A › Our Revenues and Results of Operations Are Variable › We Use Artificial Intelligence in Our Business, and Challenges with Properly Managing Its Use Could Result in Reputational Harm, Competitive Harm, and Legal Liability, and Materially and Adversely Affect Our Results of Operations.

Summary · quote-checked

Added disclosure describing compliance costs, potential non-compliance, enforcement risks, penalties, customer-trust loss, and reputational damage.

The new paragraph adds substantive legal, regulatory, financial, operational, and reputational risks associated with compliance and potential non-compliance.

Why the model ranked it here

Clients should read this because non-compliance could trigger enforcement, penalties, operating restrictions, loss of customer trust, and reputational damage.

Filing text · FY2025 10-K · filed Aug 11, 2025

No corresponding language in the FY2025 10-K.

Filing text · FY2026 10-K · filed Aug 7, 2026

We are subject to various risks in the jurisdictions in which we operate related to (1) new, different, inconsistent, or even conflicting laws, rules, and regulations that may be enacted by legislative or executive bodies and/or regulatory agencies; (2) disagreements or disputes related to international trade; and (3) the interpretation and application of laws, rules, and regulations. As a public company with global operations, we are subject to the laws of multiple jurisdictions and the rules and regulations of various governing bodies, including, but not limited to, those related to import and export controls and other trade restrictions, national and economic security (including receipt or use of designated technologies), intellectual property rights, taxes, financial and other disclosures, corporate governance, data protection, privacy, anti-corruption, such as the Foreign Corrupt Practices Act and other local laws prohibiting corrupt payments to governmental officials, anti-boycott compliance, conflict minerals or other social responsibility legislation, immigration or travel regulations, antitrust regulations, foreign ownership and investment, employment and labor, product and manufacturing regulations, environmental, health, and safety requirements, human rights, and laws or regulations relating to carbon emissions, such as the recent reporting requirements imposed by the State of California that require companies to provide climate-related disclosures, as well as other laws or regulations imposed in response to climate change concerns, among others. [added] Each of these laws, rules, and regulations imposes costs on our business, including financial costs and our management's attention associated with compliance, that could adversely impact our competitive position and our ability to meet customer demand. There have been, and may continue to be, instances of our compliance policies and procedures not being effective to ensure full compliance with all of the laws, rules and regulations to which we are subject. Such instances of non-compliance have presented and may present risks to our business, including the risk of legal, administrative, or regulatory proceedings, claims, demands, inquiries or investigations, fines, criminal penalties, restrictions on our actions or conduct of our business, loss of customer trust, and reputational damage. The occurrence of any of these risks could materially and adversely affect our business, financial condition, and/or results of operations.

Cite this change

"Such instances of non-compliance have presented and may present risks to our business, including the risk of legal, administrative, or regulatory proceedings, claims, demands, inquiries or investigations, fines, criminal penalties, restrictions on our actions or conduct of our business, loss of customer trust, and reputational damage."

Lam Research, Form 10-K for FY2026, Item 1A, accession 0000707549-26-000037, filed 7 August 2026.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754926000037/lrcx-20260628.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

Show all 13 in Item 1A (9 more, in filing order)

Item 7 · MD&A

4 of 12 shown · Ordered by the model, quote-checked

01AddedItem 7 › Liquidity

Summary · quote-checked

Added disclosure of increased commercial paper issuance capacity, permitted uses of proceeds, and no outstanding borrowings as of June 28, 2026.

The new paragraph discloses a financing capacity increase, permitted use for stock repurchases, and the company’s outstanding commercial paper balance, changing liquidity and financing information.

Why the model ranked it here

The expanded commercial paper capacity and absence of borrowings change the company’s disclosed liquidity and potential funding flexibility.

Filing text · FY2025 10-K · filed Aug 11, 2025

No corresponding language in the FY2025 10-K.

Filing text · FY2026 10-K · filed Aug 7, 2026

[added] In March 2026, we increased the issuance capacity under our commercial paper program (the "CP Program") from $1.50 billion to $2.00 billion. The net proceeds from the CP Program may be used for general corporate purposes, including repurchases of our Common Stock from time to time under our stock repurchase program. As of June 28, 2026, we had no outstanding borrowings under the CP Program.

Cite this change

"In March 2026, we increased the issuance capacity under our commercial paper program (the "CP Program") from $1.50 billion to $2.00 billion."

Lam Research, Form 10-K for FY2026, Item 7, accession 0000707549-26-000037, filed 7 August 2026.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754926000037/lrcx-20260628.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

02AddedItem 7 › Income Tax Expense

Summary · quote-checked

Added disclosure of BEPS 2.0 GMT effectiveness, safe-harbor assessment, limited jurisdiction exposure, and its fiscal year 2026 tax-expense impact.

The new paragraph introduces a tax regime, compliance assessment, jurisdictional exposure, and recognized tax-expense impact, changing the disclosed tax obligation and exposure.

Why the model ranked it here

The effective global minimum tax regime creates a newly disclosed tax obligation, jurisdictional exposure, and recognized expense impact.

Filing text · FY2025 10-K · filed Aug 11, 2025

No corresponding language in the FY2025 10-K.

Filing text · FY2026 10-K · filed Aug 7, 2026

[added] The Organization for Economic Co-operation and Development's Base Erosion and Profit Shifting 2.0 ("BEPS 2.0") GMT was fully effective for us this fiscal year. We assessed GMT under currently enacted legislation and determined that we met transitional safe harbor requirements in most jurisdictions, with limited jurisdictions subject to GMT. We assessed the impact and concluded that it was not material. The impact has been included within income tax expense in fiscal year 2026.

Cite this change

"The Organization for Economic Co-operation and Development's Base Erosion and Profit Shifting 2.0 ("BEPS 2.0") GMT was fully effective for us this fiscal year."

Lam Research, Form 10-K for FY2026, Item 7, accession 0000707549-26-000037, filed 7 August 2026.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754926000037/lrcx-20260628.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

03AddedItem 7 › Revenue

Summary · quote-checked

Added disclosure that revenue is disaggregated geographically and that a significant portion is generated outside the United States.

The new paragraph discloses geographic revenue exposure and reliance on markets outside the United States, constituting substantive information about revenue concentration and dependency.

Why the model ranked it here

The disclosure establishes that the company depends materially on revenue generated outside the United States.

Filing text · FY2025 10-K · filed Aug 11, 2025

No corresponding language in the FY2025 10-K.

Filing text · FY2026 10-K · filed Aug 7, 2026

[added] We present our revenues disaggregated by geographic region based on the location of customers' facilities to which products were shipped and services were rendered. A significant portion of our revenue is generated outside of the United States.

Cite this change

"We present our revenues disaggregated by geographic region based on the location of customers' facilities to which products were shipped and services were rendered. A significant portion of our revenue is generated outside of the United States."

Lam Research, Form 10-K for FY2026, Item 7, accession 0000707549-26-000037, filed 7 August 2026.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754926000037/lrcx-20260628.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

04AddedItem 7 › Cash Flows from Financing Activities

Summary · quote-checked

Added an explanation attributing the increase in financing cash usage to stock repurchases, debt maturities, and higher dividends.

The new paragraph discloses a changed financing cash-flow amount and identifies substantive drivers, including debt repayments and increased dividend payments.

Why the model ranked it here

The increased use of financing cash for repurchases, debt maturities, and dividends shows a changed pattern of cash deployment and debt obligations.

Filing text · FY2025 10-K · filed Aug 11, 2025

No corresponding language in the FY2025 10-K.

Filing text · FY2026 10-K · filed Aug 7, 2026

[added] The increase of $781.1 million in net cash used for financing activities during fiscal year 2026 compared to fiscal year 2025 was primarily the result of increased Common Stock repurchase activity, principal payments on debt instruments resulting from maturities of our 2026 Senior Notes, and higher dividends paid associated with an increased dividend rate.

Cite this change

"The increase of $781.1 million in net cash used for financing activities during fiscal year 2026 compared to fiscal year 2025 was primarily the result of increased Common Stock repurchase activity, principal payments on debt instruments resulting from maturities of our 2026 Senior Notes, and higher dividends paid associated with an increased dividend rate."

Lam Research, Form 10-K for FY2026, Item 7, accession 0000707549-26-000037, filed 7 August 2026.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754926000037/lrcx-20260628.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

Show all 12 in Item 7 (8 more, in filing order)

What the company no longer says

Paragraphs of the prior filing that this filing dropped. Only last year's text can show these.

17 material removals

Item 1A · Risk Factors

3 of 10 shown · Ordered by the model, quote-checked

01RemovedItem 1A › Our Credit Agreements Contain Covenant Restrictions That May Limit Our Ability to Operate Our Business

Summary · quote-checked

The current filing removes disclosure about losses and recovery limitations arising from counterparty insolvency, bankruptcy, default, or failure.

A counterparty liquidity and default risk, including potential significant losses affecting results and financial condition, is no longer disclosed; this is a substantive risk change.

Why the model ranked it here

This removes disclosure of counterparty insolvency and default exposure that could limit recoveries and harm results and financial condition.

Filing text · FY2025 10-K · filed Aug 11, 2025

If One or More of Our Counterparty Financial Institutions Default on Their Obligations To Us or Fail, We May Incur Significant Losses As part of our hedging activities, we enter into transactions involving derivative financial instruments, which may include forward contracts, option contracts, collars and swaps with various financial institutions. In addition, we have significant amounts of cash, cash equivalents and other investments on deposit or in accounts with banks or other financial institutions both in and out of the United States. As a result, we are exposed to the risk of default by or failure of counterparty financial institutions, which may be heightened during economic downturns and periods of uncertainty in the financial markets. If one of our counterparties were to [removed] become insolvent or file for bankruptcy, our ability to recover losses incurred as a result of default, or our assets deposited or held in accounts with such counterparty, may be limited by the counterparty's liquidity or the applicable laws governing the insolvency or bankruptcy proceedings. In the event of default or failure of one or more of our counterparties, we could incur significant losses, which could negatively impact our results of operations and financial condition.

Filing text · FY2026 10-K · filed Aug 7, 2026

No corresponding language in the FY2026 10-K.

Cite this change

"become insolvent or file for bankruptcy, our ability to recover losses incurred as a result of default, or our assets deposited or held in accounts with such counterparty, may be limited by the counterparty's liquidity or the applicable laws governing the insolvency or bankruptcy proceedings. In the event of default or failure of one or more of our counterparties, we could incur significant losses, which could negatively impact our results of operations and financial condition."

Lam Research, Form 10-K for FY2025, Item 1A, accession 0000707549-25-000075, filed 11 August 2025.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754925000075/lrcx-20250629.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

02RemovedItem 1A › Epidemics, Pandemics or Outbreaks of Diseases May Adversely Impact Our Business, Operations, and Financial Results

Summary · quote-checked

The company removed a risk disclosure about epidemics, pandemics, disease outbreaks, governmental containment measures, and resulting business restrictions.

The removed paragraph disclosed a distinct operational and financial risk, including potential quarantines, travel bans, shutdowns, and stay-at-home orders; its removal changes the substance of disclosed risks.

Why the model ranked it here

This removes broad disclosure of pandemic and disease-outbreak risks that could restrict operations through government containment measures and business shutdowns.

Filing text · FY2025 10-K · filed Aug 11, 2025

[removed] Epidemics, pandemics or outbreaks of diseases may arise at any time and may have significant business, operational, and financial impacts. For example, the COVID-19 pandemic has in the past and additional global heath crises may in the future result in efforts by national, state and local governments worldwide to control the applicable disease's spread. Such governmental efforts may result in measures aimed at containing the applicable disease such as quarantines, travel bans, shutdowns, and shelter in place or "stay at home" orders, which collectively have the potential to significantly restrict the ability of businesses to operate. In addition, restrictions resulting from global health crises and related measures aimed at containing the applicable disease, incidents of confirmed or suspected infections within our workforce or those of our suppliers or other business partners, and efforts to act in the best interests of our employees, customers, and suppliers, in connection with a pandemic or disease outbreak, may affect our business and operations by, among other things, causing facility closures, production delays and capacity limitations; disrupting production by our supply chain; disrupting the transport of goods from our supply chain to us and from us to our customers; requiring modifications to our business processes; requiring the implementation of business continuity plans; requiring the development and qualification of alternative sources of supply; requiring the implementation of social distancing measures that impede manufacturing processes; disrupting business travel; disrupting our ability to staff our on-site manufacturing and research and development facilities; delaying capital expansion projects; and necessitating teleworking by portions of our workforce. These impacts may cause delays in product shipments and product development, increases in costs, and decreases in revenue, profitability and cash from operations, which may cause an adverse effect on our results of operations that may be material. Global health crises may also have significant macroeconomic impacts, including, but not limited to, significant disruption of global financial markets, increases in levels of unemployment, and economic uncertainty. This may lead to significant negative impacts on customer spending, demand for our products, the ability of our customers to pay, our financial condition and the financial condition of our suppliers, and our access to external sources of financing to fund our operations and capital expenditures.

Filing text · FY2026 10-K · filed Aug 7, 2026

No corresponding language in the FY2026 10-K.

Cite this change

"Epidemics, pandemics or outbreaks of diseases may arise at any time and may have significant business, operational, and financial impacts. For example, the COVID-19 pandemic has in the past and additional global heath crises may in the future result in efforts by national, state and local governments worldwide to control the applicable disease's spread. Such governmental efforts may result in measures aimed at containing the applicable disease such as quarantines, travel bans, shutdowns, and shelter in place or "stay at home" orders, which collectively have the potential to significantly restrict the ability of businesses to operate."

Lam Research, Form 10-K for FY2025, Item 1A, accession 0000707549-25-000075, filed 11 August 2025.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754925000075/lrcx-20250629.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

03RemovedItem 1A › Epidemics, Pandemics or Outbreaks of Diseases May Adversely Impact Our Business, Operations, and Financial Results

Summary · quote-checked

Removed a paragraph describing pandemic and disease-outbreak risks to operations, supply chains, shipments, costs, revenue, profitability, and cash from operations.

The removed paragraph disclosed multiple operational, financial, workforce, and macroeconomic risks from global health crises, so its deletion changes the substance of the risk disclosure.

Why the model ranked it here

This removes detailed disclosure of health-crisis effects on facilities, supply chains, shipments, staffing, production, revenue, profitability, and cash generation.

Filing text · FY2025 10-K · filed Aug 11, 2025

Epidemics, pandemics or outbreaks of diseases may arise at any time and may have significant business, operational, and financial impacts. For example, the COVID-19 pandemic has in the past and additional global heath crises may in the future result in efforts by national, state and local governments worldwide to control the applicable disease's spread. Such governmental efforts may result in measures aimed at containing the applicable disease such as quarantines, travel bans, shutdowns, and shelter in place or "stay at home" orders, which collectively have the potential to significantly restrict the ability of businesses to operate. [removed] In addition, restrictions resulting from global health crises and related measures aimed at containing the applicable disease, incidents of confirmed or suspected infections within our workforce or those of our suppliers or other business partners, and efforts to act in the best interests of our employees, customers, and suppliers, in connection with a pandemic or disease outbreak, may affect our business and operations by, among other things, causing facility closures, production delays and capacity limitations; disrupting production by our supply chain; disrupting the transport of goods from our supply chain to us and from us to our customers; requiring modifications to our business processes; requiring the implementation of business continuity plans; requiring the development and qualification of alternative sources of supply; requiring the implementation of social distancing measures that impede manufacturing processes; disrupting business travel; disrupting our ability to staff our on-site manufacturing and research and development facilities; delaying capital expansion projects; and necessitating teleworking by portions of our workforce. These impacts may cause delays in product shipments and product development, increases in costs, and decreases in revenue, profitability and cash from operations, which may cause an adverse effect on our results of operations that may be material. Global health crises may also have significant macroeconomic impacts, including, but not limited to, significant disruption of global financial markets, increases in levels of unemployment, and economic uncertainty. This may lead to significant negative impacts on customer spending, demand for our products, the ability of our customers to pay, our financial condition and the financial condition of our suppliers, and our access to external sources of financing to fund our operations and capital expenditures.

Filing text · FY2026 10-K · filed Aug 7, 2026

No corresponding language in the FY2026 10-K.

Cite this change

"In addition, restrictions resulting from global health crises and related measures aimed at containing the applicable disease, incidents of confirmed or suspected infections within our workforce or those of our suppliers or other business partners, and efforts to act in the best interests of our employees, customers, and suppliers, in connection with a pandemic or disease outbreak, may affect our business and operations by, among other things, causing facility closures, production delays and capacity limitations; disrupting production by our supply chain; disrupting the transport of goods from our supply chain to us and from us to our customers; requiring modifications to our business processes; requiring the implementation of business continuity plans; requiring the development and qualification of alternative sources of supply; requiring the implementation of social distancing measures that impede manufacturing processes; disrupting business travel; disrupting our ability to staff our on-site manufacturing and research and development facilities; delaying capital expansion projects; and necessitating teleworking by portions of our workforce."

Lam Research, Form 10-K for FY2025, Item 1A, accession 0000707549-25-000075, filed 11 August 2025.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754925000075/lrcx-20250629.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

04RemovedItem 1A › Epidemics, Pandemics or Outbreaks of Diseases May Adversely Impact Our Business, Operations, and Financial Results

Summary · quote-checked

Removed a statement that epidemics, pandemics or disease outbreaks may negatively affect customers, suppliers, financing access and company results.

The removed paragraph disclosed dependencies and potential adverse effects on demand, customer payments, supplier financial condition and external financing, changing the stated risk disclosure.

Why the model ranked it here

This removes disclosure of health-crisis effects on customer demand and payments, supplier financial condition, and access to external financing.

Filing text · FY2025 10-K · filed Aug 11, 2025

Epidemics, pandemics or outbreaks of diseases may arise at any time and may have significant business, operational, and financial impacts. For example, the COVID-19 pandemic has in the past and additional global heath crises may in the future result in efforts by national, state and local governments worldwide to control the applicable disease's spread. Such governmental efforts may result in measures aimed at containing the applicable disease such as quarantines, travel bans, shutdowns, and shelter in place or "stay at home" orders, which collectively have the potential to significantly restrict the ability of businesses to operate. In addition, restrictions resulting from global health crises and related measures aimed at containing the applicable disease, incidents of confirmed or suspected infections within our workforce or those of our suppliers or other business partners, and efforts to act in the best interests of our employees, customers, and suppliers, in connection with a pandemic or disease outbreak, may affect our business and operations by, among other things, causing facility closures, production delays and capacity limitations; disrupting production by our supply chain; disrupting the transport of goods from our supply chain to us and from us to our customers; requiring modifications to our business processes; requiring the implementation of business continuity plans; requiring the development and qualification of alternative sources of supply; requiring the implementation of social distancing measures that impede manufacturing processes; disrupting business travel; disrupting our ability to staff our on-site manufacturing and research and development facilities; delaying capital expansion projects; and necessitating teleworking by portions of our workforce. These impacts may cause delays in product shipments and product development, increases in costs, and decreases in revenue, profitability and cash from operations, which may cause an adverse effect on our results of operations that may be material. Global health crises may also have significant macroeconomic impacts, including, but not limited to, significant disruption of global financial markets, increases in levels of unemployment, and economic uncertainty. [removed] This may lead to significant negative impacts on customer spending, demand for our products, the ability of our customers to pay, our financial condition and the financial condition of our suppliers, and our access to external sources of financing to fund our operations and capital expenditures.

Filing text · FY2026 10-K · filed Aug 7, 2026

No corresponding language in the FY2026 10-K.

Cite this change

"This may lead to significant negative impacts on customer spending, demand for our products, the ability of our customers to pay, our financial condition and the financial condition of our suppliers, and our access to external sources of financing to fund our operations and capital expenditures."

Lam Research, Form 10-K for FY2025, Item 1A, accession 0000707549-25-000075, filed 11 August 2025.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754925000075/lrcx-20250629.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

05RemovedItem 1A › We Are Exposed to Various Risks from Our Regulatory Environment

Summary · quote-checked

The filing removed disclosure about potential global minimum tax changes under the BEPS 2.0 project and their possible effect on the effective tax rate.

The removed paragraph disclosed a regulatory tax risk, uncertainty, and potential material impact on the effective tax rate, so its deletion changes the disclosed exposure.

Why the model ranked it here

This removes disclosure of potential global minimum tax changes and their possible effect on the effective tax rate.

Filing text · FY2025 10-K · filed Aug 11, 2025

[removed] Recommendations made by the Organization for Economic Co-operation and Development's Base Erosion and Profit Shifting 2.0 ("BEPS 2.0") project have the potential to lead to changes in the tax laws in numerous countries, including the implementation of a global minimum tax. Several countries around the world have enacted or proposed changes to their existing tax laws based on these recommendations. As each country in which we operate evaluates their alignment with the recommendations and enacts minimum tax rules, the ultimate impact of any such changes on our effective tax rate remains uncertain. When fully enacted, such changes could have a material impact on our effective tax rate. We will continue to monitor the progress of the BEPS 2.0 implementation.

Filing text · FY2026 10-K · filed Aug 7, 2026

No corresponding language in the FY2026 10-K.

Cite this change

"Recommendations made by the Organization for Economic Co-operation and Development's Base Erosion and Profit Shifting 2.0 ("BEPS 2.0") project have the potential to lead to changes in the tax laws in numerous countries, including the implementation of a global minimum tax. Several countries around the world have enacted or proposed changes to their existing tax laws based on these recommendations. As each country in which we operate evaluates their alignment with the recommendations and enacts minimum tax rules, the ultimate impact of any such changes on our effective tax rate remains uncertain. When fully enacted, such changes could have a material impact on our effective tax rate. We will continue to monitor the progress of the BEPS 2.0 implementation."

Lam Research, Form 10-K for FY2025, Item 1A, accession 0000707549-25-000075, filed 11 August 2025.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754925000075/lrcx-20250629.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

06RemovedItem 1A › Our Ability to Attract, Retain, and Motivate Key Employees Is Critical to Our Success

Summary · quote-checked

Removed disclosure of operational and financial risks from acquisitions, dispositions, personnel reductions, and inadequate management, personnel, or systems.

The removed paragraph disclosed substantive business risks and potential adverse effects, not merely wording or formatting.

Why the model ranked it here

This removes disclosure of operational and financial risks associated with acquisitions, dispositions, personnel reductions, and related management or systems challenges.

Filing text · FY2025 10-K · filed Aug 11, 2025

If We Choose to Acquire or Dispose of Businesses, Product Lines, and Technologies, We May Encounter Unforeseen Costs and Difficulties That Could Impair Our Financial Performance An important element of our management strategy is to review acquisition prospects that would complement our existing products, augment our market coverage and distribution ability, enhance our technological capabilities, or accomplish other strategic objectives. As a result, we may seek to make acquisitions of complementary companies, products, or technologies, or we may reduce or dispose of certain product lines or technologies that no longer fit our long-term strategies. For regulatory or other reasons, we may not be successful in our attempts to acquire or dispose of businesses, products, or technologies, resulting in significant financial costs, reduced or lost opportunities, and diversion of management's attention. Managing an acquired business, disposing of product [removed] technologies, or reducing personnel entails numerous operational and financial risks, including difficulties in assimilating acquired operations and new personnel or separating existing business or product groups, diversion of management's attention away from other business concerns, amortization of acquired intangible assets, adverse customer reaction to our decision to cease support for a product, and potential loss of key employees or customers of acquired or disposed operations. There can be no assurance that we will be able to achieve and manage successfully any such integration of potential acquisitions, disposition of product lines or technologies, or reduction in personnel, or that our management, personnel, or systems will be adequate to support continued operations. Any such inabilities or inadequacies could have a material adverse effect on our business, operating results, financial condition, and/or cash flows.

Filing text · FY2026 10-K · filed Aug 7, 2026

No corresponding language in the FY2026 10-K.

Cite this change

"technologies, or reducing personnel entails numerous operational and financial risks, including difficulties in assimilating acquired operations and new personnel or separating existing business or product groups, diversion of management's attention away from other business concerns, amortization of acquired intangible assets, adverse customer reaction to our decision to cease support for a product, and potential loss of key employees or customers of acquired or disposed operations."

Lam Research, Form 10-K for FY2025, Item 1A, accession 0000707549-25-000075, filed 11 August 2025.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754925000075/lrcx-20250629.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

07RemovedItem 1A › Our Revenues and Operating Results Are Variable

Summary · quote-checked

Removed disclosure of the impact of reductions in government spending on revenues and operating results.

The removed bullet identifies a potential government-spending-related impact on business results, changing the disclosed risk factors.

Filing text · FY2025 10-K · filed Aug 11, 2025

[removed] • the impact of reductions in government spending;

Filing text · FY2026 10-K · filed Aug 7, 2026

No corresponding language in the FY2026 10-K.

Cite this change

"• the impact of reductions in government spending;"

Lam Research, Form 10-K for FY2025, Item 1A, accession 0000707549-25-000075, filed 11 August 2025.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754925000075/lrcx-20250629.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

08RemovedItem 1A › Our Revenues and Operating Results Are Variable

Summary · quote-checked

The risk-factor bullet identifying procurement shortages was removed.

The removed text identifies a specific operational risk, so its deletion changes the substance of the disclosed risks.

Filing text · FY2025 10-K · filed Aug 11, 2025

[removed] • procurement shortages;

Filing text · FY2026 10-K · filed Aug 7, 2026

No corresponding language in the FY2026 10-K.

Cite this change

"• procurement shortages;"

Lam Research, Form 10-K for FY2025, Item 1A, accession 0000707549-25-000075, filed 11 August 2025.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754925000075/lrcx-20250629.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

09RemovedItem 1A › Our Revenues and Operating Results Are Variable

Summary · quote-checked

Removed a disclosure that inflation or interest rates can affect revenues and operating results.

The removed bullet identifies inflation and interest rates as factors affecting operating results, changing the disclosed risk exposure rather than merely rephrasing text.

Filing text · FY2025 10-K · filed Aug 11, 2025

[removed] • effects of inflation or interest rates; and

Filing text · FY2026 10-K · filed Aug 7, 2026

No corresponding language in the FY2026 10-K.

Cite this change

"• effects of inflation or interest rates; and"

Lam Research, Form 10-K for FY2025, Item 1A, accession 0000707549-25-000075, filed 11 August 2025.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754925000075/lrcx-20250629.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

10RemovedItem 1A › FINANCIAL, ACCOUNTING AND CAPITAL MARKETS RISKS

Summary · quote-checked

The filing removed a risk concerning the impact of reductions in government spending.

A disclosed external risk was dropped, changing the substance of the company’s stated risk factors.

Filing text · FY2025 10-K · filed Aug 11, 2025

[removed] • the impact of reductions in government spending;

Filing text · FY2026 10-K · filed Aug 7, 2026

No corresponding language in the FY2026 10-K.

Cite this change

"• the impact of reductions in government spending;"

Lam Research, Form 10-K for FY2025, Item 1A, accession 0000707549-25-000075, filed 11 August 2025.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754925000075/lrcx-20250629.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

Show fewer in Item 1A

Item 7 · MD&A

2 of 7 shown · Ordered by the model, quote-checked

01RemovedItem 7 › Restructuring Charges, Net

Summary · quote-checked

The current filing removes disclosure of the restructuring plan, employee terminations, manufacturing relocation, and completion status.

The removed paragraph disclosed restructuring actions, employee-related costs, manufacturing relocation, and the plan’s completion, changing the substance of the MD&A disclosure.

Why the model ranked it here

The removal obscures the company’s restructuring actions, workforce reductions, manufacturing relocation, and completion status.

Filing text · FY2025 10-K · filed Aug 11, 2025

[removed] In fiscal year 2023, we initiated a restructuring plan, that continued into fiscal year 2024, designed to better align our cost structure with our outlook for the economic environment and business opportunities. Under the plan, we terminated approximately 1,760 employees, incurring expenses related to employee severance and separation costs. Employee severance and separation costs are primarily related to severance, non-cash severance, including equity award compensation expense, pension and other termination benefits. Additionally, we made a strategic decision to relocate certain manufacturing activities to pre-existing facilities. The restructuring plan was substantially complete as of June 30, 2024.

Filing text · FY2026 10-K · filed Aug 7, 2026

No corresponding language in the FY2026 10-K.

Cite this change

"In fiscal year 2023, we initiated a restructuring plan, that continued into fiscal year 2024, designed to better align our cost structure with our outlook for the economic environment and business opportunities. Under the plan, we terminated approximately 1,760 employees, incurring expenses related to employee severance and separation costs. Employee severance and separation costs are primarily related to severance, non-cash severance, including equity award compensation expense, pension and other termination benefits. Additionally, we made a strategic decision to relocate certain manufacturing activities to pre-existing facilities. The restructuring plan was substantially complete as of June 30, 2024."

Lam Research, Form 10-K for FY2025, Item 7, accession 0000707549-25-000075, filed 11 August 2025.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754925000075/lrcx-20250629.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

02RemovedItem 7 › Restructuring Charges, Net

Summary · quote-checked

The restructuring charges table was removed from the MD&A.

The disappearance of a numeric table changes the disclosure of restructuring charges and their reported amounts, rather than merely rolling forward recurring figures.

Why the model ranked it here

The removed table eliminates the disclosed scale and trend of restructuring charges from the MD&A.

Filing text · FY2025 10-K · filed Aug 11, 2025
[removed] |[removed] Year Ended | Change[removed] June 29, 2025 | June 30, 2024 | June 25, 2023 | FY25 vs. FY24 | FY24 vs. FY23[removed] |[removed] (in thousands, except percentages and basis points)[removed] Restructuring charges, net | $ | - | $ | 61,562 | $ | 120,316 | $ | (61,562) | (100.0) | % | $ | (58,754) | (48.8) | %[removed] Percent of revenue | - | % | 0.4 | % | 0.7 | % | - 40 bps | - 30 bps
Filing text · FY2026 10-K · filed Aug 7, 2026

No corresponding language in the FY2026 10-K.

Cite this change

"Restructuring charges, net | $ | - | $ | 61,562 | $ | 120,316 | $ | (61,562) | (100.0) | % | $ | (58,754) | (48.8) | %"

Lam Research, Form 10-K for FY2025, Item 7, accession 0000707549-25-000075, filed 11 August 2025.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754925000075/lrcx-20250629.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

Show all 7 in Item 7 (5 more, in filing order)

What the company says differently

Paragraphs that changed between the two filings, shown as a word diff.

69 material changes

Item 1A · Risk Factors

3 of 47 shown · Ordered by the model, quote-checked

01ChangedItem 1A › Our Revenues and Results of Operations Are Variable › We Use Artificial Intelligence in Our Business, and Challenges with Properly Managing Its Use Could Result in Reputational Harm, Competitive Harm, and Legal Liability, and Materially and Adversely Affect Our Results of Operations.

Summary · quote-checked

The risk disclosure now states that steel and aluminum tariffs increased manufacturing costs and adversely impacted margins in fiscal year 2026.

The paragraph changes from potential tariff effects to a disclosed realized impact on manufacturing costs and margins, substantively changing the reported exposure.

Why the model ranked it here

This is a realized tariff impact that increased manufacturing costs and reduced margins, changing the exposure from hypothetical to experienced.

Filing text · FY2025 10-K · filed Aug 11, 2025

Tariffs, export controls, additional taxes, trade barriers, sanctions, the termination or modification of trade agreements, trade zones, and other duty mitigation initiatives, and any reciprocal retaliatory actions, can increase our manufacturing costs, decrease margins, reduce the competitiveness of our products, disrupt our supply chain operations, or inhibit our ability to sell products or provide services, which has had and in the future could have a material adverse effect on our business, results of operations, or financial [removed] conditions. Certain of our international sales depend on our ability to obtain export licenses from the U.S. or foreign [removed] governments, and our inability to obtain such licenses, or an expansion of the number or kinds of sales for which export licenses are required, has limited and could in the future further limit the market for our products and has had and could in the future have an adverse impact on our revenues. As is discussed below under the heading "Our Sales to Customers in China, a Significant Region for Us, Have Been Impacted, and are Likely to Be Materially and Adversely Affected by Export License Requirements and Other Regulatory Changes, or Other Governmental Actions in the Course of the Trade Relationship Between the U.S. and China," the U.S. government has in recent years imposed new controls, including expanded export license requirements and restrictions on sales to certain Chinese entities that significantly impact trade with China. In addition, the U.S. government has an ongoing process of assessing technologies that may be subject to new or additional export controls, and it is possible that such additional controls, if and when imposed, could further adversely impact our ability to sell our products outside the U.S. The implementation by the U.S. government of broad export controls restricting access to our technology (such as recent controls limiting exports to China) may cause customers with international operations to reconsider their use of and reliance on our products, which could adversely impact our future revenue and profits and strengthen competitors who are not subject to such restrictions. Furthermore, there are risks that foreign governments may, among other things, take retaliatory actions; insist on the use of local suppliers; compel companies to partner with local companies to design and supply equipment on a local basis, requiring the transfer of intellectual property rights and/or local manufacturing; utilize their influence over their judicial systems to respond to intellectual property disputes or issues; and provide special incentives to government-backed local customers to buy from local competitors, even if their products are inferior to ours; all of which could adversely impact our ability to compete as well as our revenues and margins.

Filing text · FY2026 10-K · filed Aug 7, 2026

Tariffs, export controls, additional taxes, trade barriers, sanctions, the termination or modification of trade agreements, trade zones, and other duty mitigation initiatives, and any reciprocal retaliatory actions, can increase our manufacturing costs, decrease margins, reduce the competitiveness of our products, disrupt our supply chain operations, or inhibit our ability to sell products or provide services, [added] all of which has had and in the future could have a material adverse effect on our business, results of operations, or financial [added] condition. For example, our business requires steel and aluminum to manufacture our products, and the imposition of tariffs on steel and aluminum imports into the United States increased our manufacturing costs in fiscal year 2026, which adversely impacted our margins. Certain of our international sales depend on our ability to obtain export licenses from the U.S. or foreign [added] governments. Our inability to obtain such licenses, or an expansion of the number or kinds of sales for which export licenses are required, has limited and could in the future further limit the market for our products and has had and could in the future have an adverse impact on our revenues. As is discussed below under the heading "Our Sales to Customers in China, a Significant Region for Us, Have Been Impacted, and are Likely to Be Materially and Adversely Affected by Export License Requirements and Other Regulatory Changes, or Other Governmental Actions in the Course of the Trade Relationship Between the U.S. and China," the U.S. government has in recent years imposed new controls, including expanded export license requirements and restrictions on sales to certain Chinese entities that significantly impact trade with China. In addition, the U.S. government has an ongoing process of assessing technologies that may be subject to new or additional export controls, and it is possible that such additional controls, if and when imposed, could further adversely impact our ability to sell our products outside the United States. The implementation by the U.S. government of broad export controls restricting access to our technology (such as recent controls limiting exports to China) may cause customers with international operations to reconsider their use of and reliance on our products, which could adversely impact our future revenue and profits and strengthen competitors who are not subject to such restrictions. Furthermore, there are risks that foreign governments may, among other things, take retaliatory actions; insist on the use of local suppliers; compel companies to partner with local companies to design and supply equipment on a local basis, requiring the transfer of intellectual property rights and/or local manufacturing; utilize their influence over their judicial systems to respond to intellectual property disputes or issues; and provide special incentives to government-backed local customers to buy from local competitors, even if their products are inferior to ours; all of which could adversely impact our ability to compete as well as our revenues and margins. For example, China is the primary source of supply of certain rare earth elements critical to the manufacture of certain of our products. The Chinese government has imposed export controls and license requirements on certain rare earth elements and on certain products that contain Chinese-origin rare earth elements that are manufactured outside of China (which have been suspended in part until November 2026 (unless extended)) and could expand such controls or licensing requirements in the future. Such measures could delay or prevent our suppliers from sourcing the materials, or producing the components, required for us to manufacture our products, and increase the costs of such materials or components. In addition, to the extent these controls require us to obtain export licenses for certain products manufactured outside of China, we would experience increased compliance burdens, may be unable to obtain the required licenses, and may be unable to obtain materials or components necessary to meet our production requirements or product specifications in a timely manner, or at all, or on commercially acceptable terms. The occurrence of any of these risks could materially and adversely affect our business, results of operations, financial condition, and margins.

Cite this change

"For example, our business requires steel and aluminum to manufacture our products, and the imposition of tariffs on steel and aluminum imports into the United States increased our manufacturing costs in fiscal year 2026, which adversely impacted our margins."

Lam Research, Form 10-K for FY2026, Item 1A, accession 0000707549-26-000037, filed 7 August 2026.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754926000037/lrcx-20260628.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

02ChangedItem 1A › Our Revenues and Results of Operations Are Variable › We Use Artificial Intelligence in Our Business, and Challenges with Properly Managing Its Use Could Result in Reputational Harm, Competitive Harm, and Legal Liability, and Materially and Adversely Affect Our Results of Operations.

Summary · quote-checked

The risk discussion adds a specific 2026 Middle East conflict, commodity disruptions, adverse effects already experienced, and potential sanctions or trade restrictions affecting semiconductor inputs.

Although several phrases are reworded, the paragraph newly discloses a geopolitical event, realized business effects, commodity dependencies, and possible future disruptions to critical semiconductor inputs.

Why the model ranked it here

This disclosure identifies a specific geopolitical disruption that has already affected commodity supply and prices and could impair access to critical inputs.

Filing text · FY2025 10-K · filed Aug 11, 2025

There is inherent [removed] risk, based on the complex relationships among the world's major trading nations, that political, diplomatic and national security influences can lead to trade disputes, impacts and/or disruptions, in particular those affecting the semiconductor industry. This can adversely affect our business [removed] with China, Japan, Korea, and/or Taiwan and perhaps the entire Asia Pacific region or [removed] global economy. A significant trade dispute, impact, and/or disruption in any area where we do business could have a materially adverse impact on our future [removed] revenue and profits.

Filing text · FY2026 10-K · filed Aug 7, 2026

There is inherent [added] risk that political, diplomatic and national security influences can lead to trade disputes, impacts and/or disruptions, in particular those affecting the semiconductor industry. This can adversely affect our business [added] in China, Japan, Korea, and/or Taiwan and perhaps the entire Asia Pacific region or [added] worldwide. A significant trade dispute, impact, and/or disruption in any area where we do business could have a materially adverse impact on our future [added] results of operations and cash flows. For example, the conflict that began in February 2026 between the United States, Israel, a number of states in the Persian Gulf, and Iran has led to significant regional instability and disruption in the Middle East, including the closure of or restrictions on the Strait of Hormuz, threatened or actual attacks on vessels in the Red Sea, and threatened or actual attacks on transportation and energy infrastructure, which has significantly and adversely affected the supply and prices of oil, refined oil products and byproducts, liquid natural gas, as well as certain other industrial commodities, such as aluminum, helium, bromine, and sulfur. Some of these commodities are important to the semiconductor industry. As a result, this instability and disruption has adversely affected, and may in the future materially and adversely affect, our business, results of operations, and financial condition. The extent to which we may be affected by this conflict will depend on various factors, including the scope, severity, and duration of the conflict and the extent to which the conflict, or additional laws, sanctions, or trade restrictions arising from or related to the conflict, further disrupt the availability or cost of critical inputs used in the semiconductor industry. Continuation or escalation of this conflict may also magnify the impact of other risks identified in this 2026 Form 10-K.

Cite this change

"For example, the conflict that began in February 2026 between the United States, Israel, a number of states in the Persian Gulf, and Iran has led to significant regional instability and disruption in the Middle East, including the closure of or restrictions on the Strait of Hormuz, threatened or actual attacks on vessels in the Red Sea, and threatened or actual attacks on transportation and energy infrastructure, which has significantly and adversely affected the supply and prices of oil, refined oil products and byproducts, liquid natural gas, as well as certain other industrial commodities, such as aluminum, helium, bromine, and sulfur."

Lam Research, Form 10-K for FY2026, Item 1A, accession 0000707549-26-000037, filed 7 August 2026.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754926000037/lrcx-20260628.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

03Figures updatedItem 1A › Our Revenues and Results of Operations Are Variable › We Use Artificial Intelligence in Our Business, and Challenges with Properly Managing Its Use Could Result in Reputational Harm, Competitive Harm, and Legal Liability, and Materially and Adversely Affect Our Results of Operations.

Summary · quote-checked

Senior unsecured notes outstanding decreased, while the commercial paper program capacity increased; the revolving credit facility figures remained unchanged.

These figures change the stated debt exposure and available borrowing capacity, so a reader could draw a different conclusion about obligations and liquidity.

Why the model ranked it here

The changed debt outstanding and borrowing capacity alter the stated balance between financial obligations and available liquidity.

Filing text · FY2025 10-K · filed Aug 11, 2025

Our Leverage and Debt Service Obligations May Adversely Affect Our Financial Condition, Results of Operations, and Earnings per Share We have [removed] $4.5 billion in aggregate principal amount of senior unsecured notes outstanding (the "Senior Notes"). Additionally, we have funding available to us under our [removed] $1.5 billion commercial paper program and our [removed] $2.0 billion revolving credit facility, which serves as a backstop to our commercial paper program. Our revolving credit facility also includes an option to increase the amount up to an additional $750.0 million, for a potential total commitment of $2.75 billion. We may, in the future, decide to enter into additional debt arrangements.

Filing text · FY2026 10-K · filed Aug 7, 2026

We have [added] $3.75 billion in aggregate principal amount of senior unsecured notes outstanding (the "Senior Notes"). Additionally, we have funding available to us under our [added] $2.00 billion commercial paper program and our [added] $2.00 billion revolving credit facility, which serves as a backstop to our commercial paper program. Our revolving credit facility also includes an option to increase the amount up to an additional $750.0 million, for a potential total commitment of $2.75 billion. We may, in the future, decide to enter into additional debt arrangements.

Cite this change

"We have $3.75 billion in aggregate principal amount of senior unsecured notes outstanding (the "Senior Notes"). Additionally, we have funding available to us under our $2.00 billion commercial paper program"

Lam Research, Form 10-K for FY2026, Item 1A, accession 0000707549-26-000037, filed 7 August 2026.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754926000037/lrcx-20260628.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

Show all 47 in Item 1A (44 more, in filing order)

Item 7 · MD&A

2 of 22 shown · Ordered by the model, quote-checked

01ChangedItem 7 › Liquidity and Capital Resources

Summary · quote-checked

Gross cash balances decreased year over year, reversing the prior increase and changing the stated primary cash-flow drivers.

The paragraph changes from an increase to a decrease and reverses the presentation of operating cash flow versus cash uses, substantively changing the liquidity narrative.

Why the model ranked it here

The liquidity narrative reverses from growing cash balances to declining balances, with cash uses now outweighing operating cash generation.

Filing text · FY2025 10-K · filed Aug 11, 2025

Total gross cash, cash equivalents, and restricted cash balances were [removed] $6.4 billion at the end of fiscal year [removed] 2025 compared to [removed] $5.9 billion at the end of fiscal year [removed] 2024. This increase was primarily due to [removed] cash provided by operating activities, partially offset by Common Stock repurchases in connection with our stock repurchase program, dividends paid, capital expenditures, and principal payments on debt [removed] instruments.

Filing text · FY2026 10-K · filed Aug 7, 2026

Total gross cash, cash equivalents, and restricted cash balances were [added] $5.60 billion at the end of fiscal year [added] 2026 compared to [added] $6.41 billion at the end of fiscal year [added] 2025. This decrease was primarily due to Common Stock repurchases in connection with our stock repurchase program, dividends paid, capital expenditures, and principal payments on debt [added] instruments, partially offset by cash provided by operating activities.

Cite this change

"Total gross cash, cash equivalents, and restricted cash balances were $5.60 billion at the end of fiscal year 2026 compared to $6.41 billion at the end of fiscal year 2025. This decrease was primarily due to Common Stock repurchases in connection with our stock repurchase program, dividends paid, capital expenditures, and principal payments on debt instruments, partially offset by cash provided by operating activities."

Lam Research, Form 10-K for FY2026, Item 7, accession 0000707549-26-000037, filed 7 August 2026.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754926000037/lrcx-20260628.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

02SplitItem 7 › Liquidity

Summary · quote-checked

The MD&A no longer states the credit facility amendment’s increased commitment, extended maturity, and expansion option, retaining only a cross-reference to Note 14.

The removed text disclosed substantive credit-facility commitments and maturity terms; under the rubric, dropping an obligation or dependency is material, despite the updated cross-reference year.

Why the model ranked it here

The MD&A removes disclosure of the credit facility’s commitment, maturity, and expansion terms, obscuring important financing capacity and dependency information.

Filing text · FY2025 10-K · filed Aug 11, 2025

[removed] In January 2025, we entered into a Third Amended and Restated Credit Agreement. The amendment increased the unsecured revolving credit facility commitment from $1.5 billion to $2.0 billion and extended the maturity of the facility from June 2026 to January 2030. The facility provides for an expansion option that will allow us, subject to certain requirements, to request an increase in the facility of up to an additional $750 million, for a potential total commitment of $2.75 billion. Please refer to Note 14, "Long-term Debt and Other Borrowings" to our Consolidated Financial Statements, included in Part II, Item 8 of this [removed] 2025 Form 10-K for additional information.

Filing text · FY2026 10-K · filed Aug 7, 2026

Please refer to Note 14, "Long-term Debt and Other Borrowings" to our Consolidated Financial Statements, included in Part II, Item 8 of this [added] 2026 Form 10-K for additional information.

Cite this change

"Please refer to Note 14, "Long-term Debt and Other Borrowings" to our Consolidated Financial Statements, included in Part II, Item 8 of this 2026 Form 10-K for additional information."

Lam Research, Form 10-K for FY2026, Item 7, accession 0000707549-26-000037, filed 7 August 2026.

Filing: https://www.sec.gov/Archives/edgar/data/707549/000070754926000037/lrcx-20260628.htm

Comparison: https://yearover.com/reports/lrcx/0000707549-26-000037?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

Show all 22 in Item 7 (20 more, in filing order)

Get this when LRCX files next

At most one email a day, and only when a company we cover files. Over the last twelve months that averaged about 5 days a month, unevenly: 12 in the busiest month and 1 in the quietest. You confirm by email first; nothing is sent until you do.

We store your email address. Nothing else. Privacy.